Perturbations in EGFR expression and signalling are implicated in several pathophysiological conditions including cancer and diabetes (Matroughi, 2010; Akhtar and Benter, 2013; Xu et al., 2017; Akhtar et al., 2018; Talukdar et al., 2020; Kumagai et al., 2021; Sharifi et al., 2021). Here, EGFR is linked to cancer.